Related Experiment Video

Updated: Jan 18, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.8K

Implementation of the VancomycIn per Pharmacy Education tRaining (VIPER) program for pharmacists at a children's

Laura Bio1, Shabnam Gaskari1, Hayden T Schwenk2

  • 1Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|June 4, 2025
PubMed

Insights

The VIPER program effectively trained pharmacists on pediatric vancomycin dosing, including AUC24 and MIPD. Pharmacists reported increased confidence and high satisfaction with this educational initiative.

Area of Science:

  • Pediatric pharmacology
  • Clinical pharmacy education
  • Therapeutic drug monitoring

Background:

  • Vancomycin dosing in children presents challenges, further complicated by new AUC24 and MIPD recommendations.
  • Pharmacists are crucial for safe and effective vancomycin use in pediatric patients.

Purpose of the Study:

  • To describe the development and implementation of the VIPER program.
  • To support a pharmacy-led vancomycin therapeutic drug monitoring (TDM) service in a children's hospital.

Main Methods:

  • The VIPER program provided education and competency assessment for pharmacists on vancomycin principles.
  • Pharmacists completed a core program before independent TDM management and annual maintenance training.
  • Pharmacist perceptions were evaluated through annual surveys.

Main Results:

  • Over 100 pharmacists were trained since 2020.
  • 89% found VIPER effective for guideline updates; 84% felt more confident in vancomycin dosing.
  • Competency assessments showed high post-course knowledge (median ≥85% yearly).

Conclusions:

  • The VIPER program successfully supported a pediatric vancomycin TDM service.
  • Pharmacists reported high satisfaction and perceived the program as effective for education and skill improvement.
Abstract

Keywords:
Bayesian forecastingarea under the curvetherapeutic drug monitoring

More Related Videos

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

1.4K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.6K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
238